3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Interventions
Specimen Handling
45
pembrolizumab
40
Magnetic Resonance Spectroscopy
32
Cyclophosphamide
31
Biopsy
31
fludarabine
27
Cetuximab
19
Cisplatin
18
Carboplatin
18
atezolizumab
15
Bevacizumab
15
Fluorouracil
14
venetoclax
13
Radiation
13
Leucovorin
13
fludarabine phosphate
12
Radiotherapy
12
Gemcitabine
12
Pemetrexed
11
Oxaliplatin
11
Nivolumab
11
Cytarabine
10
130-nm albumin-bound paclitaxel
10
Prednisone
9
Paclitaxel
9
Irinotecan
9
Fulvestrant
9
Radiosurgery
8
Platinum
8
Immunoglobulin G
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
sipuleucel-T
×
30 days
×
Clear all
NCT05806814
2026-05-27
OU-SCC-EXCITE
University of Oklahoma
Phase 1
Active not recruiting
15 enrolled